Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jun 13, 2022

50715_rns_2022-06-13_1a124698-cbd8-4f87-81f4-69db19be5022.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

13 June 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase/ Sale Totalnumberof sharesinvolved Total amountpaid / received Highest (H)prices paid/ received Lowest (L)prices paid/ received
ChinaInternationalCapitalCorporationLimited 10 June2022 Other typesof securities(e.g. equityswaps) Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later than theclose of the morning trading sessionon the trading day following theorginatingclient-driven dealing Sale 10,000 $282,000.0000 $28.2000 $28.2000

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Other typesof securities(e.g. equityswaps) Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later than theclose of the morning trading sessionon the trading day following theorginatingclient-driven dealing Purchase 10,000 $282,000.0000 $28.2000 $28.2000

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.